Fat loss
43 compounds people use for fat loss, with where each one stands in research.
Articles
Peptide198 papers~7,900 people studiedRetatrutide: what the trials show so farRetatrutide reached 25% weight loss on the top dose in one phase 3 trial but is not approved anywhere.
George Massimo Totti4 Nov 20265 min readPeptide5,810 papers~160,000 people studiedSemaglutide: what the trials showRoughly 160,000 people have enrolled in semaglutide trials on weight loss, heart risk, side effects and what happens after stopping.
George Massimo Totti4 Nov 20265 min read
George Massimo Totti4 Nov 20265 min readPeptide5,810 papers~160,000 people studiedSemaglutide: what the trials showRoughly 160,000 people have enrolled in semaglutide trials on weight loss, heart risk, side effects and what happens after stopping.
George Massimo Totti4 Nov 20265 min readCompounds
Most researched first- SemaglutideArticleOzempic, WegovyPeptideApproved medicine5,810 papers
- RetatrutideArticleLY3437943, RetaPeptidePhase 3 trials198 papers
- OxytocinPitocin, SyntocinonHormoneApproved medicine33,821 papers
- HCGhuman chorionic gonadotropin, chorionic gonadotropinHormoneApproved medicine17,137 papers
- LiraglutideSaxenda, VictozaPeptideApproved medicine5,949 papers
- HGH (somatropin)somatropin, recombinant human growth hormoneHormoneApproved medicine3,003 papers
- AICARAcadesine, AICA ribosideSmall moleculePhase 3 trials2,662 papers
- TirzepatideMounjaro, ZepboundPeptideApproved medicine2,627 papers
- Orexin-Ahypocretin-1, Hcrt-1PeptideSmall human pilots2,392 papers
- DulaglutideTrulicity, LY2189265PeptideApproved medicine1,340 papers
- Melanotan IIMT-II, MT-2PeptideSmall human pilots698 papers
- CardarineGW-501516, GW501516Small moleculePhase 2 trials338 papers
- MOTS-cMitochondrial open reading frame of the 12S rRNA type-c, MOTS-c (MDP)PeptidePhase 2 trials257 papers
- SetmelanotideImcivree, RM-493PeptideApproved medicine225 papers
- MK-677 (ibutamoren)ibutamoren, ibutamoren mesylateSmall moleculePhase 3 trials159 papers
- SR-9009SR9009, stenabolicSmall moleculeAnimal studies only154 papers
- OrforglipronFoundayo, LY3502970Small moleculeApproved medicine148 papers
- CagrilintideAM833, NNC0174-0833PeptidePhase 3 trials139 papers
- TesamorelinEgrifta, Egrifta SVPeptideApproved medicine124 papers
- SurvodutideBI 456906PeptidePhase 3 trials89 papers
- IGF-1 LR3Long R3 IGF-1, Long [Arg3] IGF-IProteinAnimal studies only86 papers
- BAM15BAM 15, mitochondrial uncoupler BAM15Small moleculeAnimal studies only72 papers
- L-Carnitine injectableLevocarnitine, Carnitor injectionAmino acidApproved medicine63 papers
- TesofensineNS2330, NS 2330Small moleculePhase 3 trials61 papers
- MazdutideIBI362, LY3305677PeptideApproved in some countries53 papers
- LGD-4033ligandrol, VK5211SARMPhase 2 trials50 papers
- ACE-031ramatercept, ActRIIB-IgG1ProteinPhase 2 trials48 papers
- GC-1sobetirome, QRX-431Small moleculePhase 1 trials43 papers
- S4andarine, S-4SARMPhase 1 trials41 papers
- MariTidemaridebart cafraglutide, AMG 133ProteinPhase 3 trials26 papers
- SR-9011SR9011Small moleculeAnimal studies only25 papers
- AOD-9604AOD9604, Tyr-hGH 177-191PeptidePhase 2 trials23 papers
- CMS-121CMS121NootropicPhase 1 trials13 papers
- AdipotideFTPP, fat-targeted proapoptotic peptidePeptidePhase 1 trials12 papers
- Follistatin-344FS344, FST-344ProteinAnimal studies only11 papers
- HGH Fragment 176-191hGH 176-191, Frag 176-191PeptideAnimal studies only10 papers
- SLU-PP-332SLU PP 332, ERR pan-agonistSmall moleculeAnimal studies only10 papers
- EloralintideLY3841136PeptidePhase 3 trials10 papers
- PetrelintideZP8396PeptidePhase 3 trials9 papers
- TrevogrumabREGN1033, SAR391786ProteinPhase 2 trials6 papers
- 5-Amino-1MQ5-amino-1-methylquinolinium, 5A1MQSmall moleculeAnimal studies only4 papers
- O-304O304, ATX-304Small moleculePhase 2 trials2 papers
- Lipo-C / MIC injectionMIC injection, Lipotropic injectionBlendLab studies only0 papers
Full study notes on every compound, with doses and safety, are in the Vault inside the Room. See the Room
Want a protocol built for you?Protocols, the full Vault and live calls with Jan, inside the Room.
Join the Room
